Showing results (111-120 of 210) with videos related to
Sort By:
Pageof 21
Environmental Health and Preventive Medicine|March 25, 2011
An intervention study to promote self-improvement of lifestyle in a Japanese community: a new health support programKumiko Fukumoto, Chang-Nian Wei, Hiroshi Matsuo, et al.Hormone Research|June 24, 2004
Preclinical Cushing's syndrome resulting from black adrenal adenoma. A case reportHiroshi Tokunagaa, Nobuhiro Miyamura, Kazunari Sasaki, et al.Journal of Diabetes Investigation|May 21, 2014
Predictors of coronary heart disease in Japanese patients with type 2 diabetes: Screening for coronary artery stenosis using multidetector computed tomographyHiroko Nishioka, Noboru Furukawa, Seiya Shimoda, et al.Journal of Clinical Lipidology|February 24, 2026
Efficacy for LDL-C-lowering and safety of pemafibrate extended-release formulation in patients with statin-intolerant hypercholesterolemia: A phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group trialShizuya Yamashita, Eiichi Araki, Hidenori Arai, et al.Biochemical and Biophysical Research Communications|January 18, 2005
Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated miceShoko Kodama, Tetsushi Toyonaga, Tatsuya Kondo, et al.Plos One|December 10, 2014
Mild electrical stimulation increases stress resistance and suppresses fat accumulation via activation of LKB1-AMPK signaling pathway in C. elegansShingo Matsuyama, Masataka Moriuchi, Mary Ann Suico, et al.Cardiovascular Diabetology|April 1, 2014
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative studyKohei Kaku, Hirotaka Watada, Yasuhiko Iwamoto, et al.Biochemical and Biophysical Research Communications|December 18, 2007
Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic miceHideo Goto, Takeshi Nishikawa, Kazuhiro Sonoda, et al.Expert Opinion on Pharmacotherapy|February 12, 2014
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, as monotherapy or in combination with other oral antidiabetic agents in Japanese patients with type 2 diabetes mellitus: multicenter, open-label, randomized controlled trialsYukio Tanizawa, Kohei Kaku, Eiichi Araki, et al.Internal Medicine (Tokyo, Japan)|August 16, 2012
Effects of olmesartan, an angiotensin II receptor blocker, on peripheral insulin sensitivity in Japanese subjects with type 2 diabetes and hypertensionSeiya Shimoda, Rieko Goto, Noboru Furukawa, et al.Pageof 21